Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 7, 2016; 22(29): 6673-6682
Published online Aug 7, 2016. doi: 10.3748/wjg.v22.i29.6673
Published online Aug 7, 2016. doi: 10.3748/wjg.v22.i29.6673
Table 2 Microbiota-based treatment in alcoholic liver disease - animal studies
Animal model | Alcohol amount | Treatment | Results | Ref. |
6-wk-old male 10 C57BL/6 mice | Lieber-DeCarli liquid diet with 10% alcohol for 6 wk | Lactobacillus rhamnosus R0011, Lactobacillus acidophilus R0052 | TLR-4 ↓ | [75] |
(1 mg/mL per day for 4 wk) | IL-1β↓ | |||
4-wk-old male 20 C57BL/6 mice (10 Normal diet, 10 High-fat diet) | Oral administration 5 g/kg per day, twice/wk, for 9 wk | Lactobacillus rhamnosus R0011, Lactobacillus acidophilus R0052 | In normal diet groups | [76] |
(1 mg/mL per day for 2 wk) | TNF-α↓ | |||
IL-1↓ | ||||
TLR4 ↓ | ||||
TLR4/GADPH ↓ | ||||
In high-fat diet groups: IL-10 ↑ | ||||
Male Sprague-Dawley rats | Dose gradually increased every 2 to 3 d up to a maximum of 8 g/kg per day by 2 wk | Oats (10 g/kg per day) | Tight junctions in colon ↓ | [79] |
Disorganization of actin cytoskeleton ↓ | ||||
6 g/kg per day for final 10 wk | Oxidative stress ↓ | |||
NO overproduction ↓ | ||||
Oxidative tissue damage ↓ | ||||
Nitrotyrosine ↓ | ||||
Carbonyl ↓ |
- Citation: Sung H, Kim SW, Hong M, Suk KT. Microbiota-based treatments in alcoholic liver disease. World J Gastroenterol 2016; 22(29): 6673-6682
- URL: https://www.wjgnet.com/1007-9327/full/v22/i29/6673.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i29.6673